Skip to Main Content
An official website of the United States government
Login Change: CDAS is now using the NIH Researcher Auth Service (RAS) to manage our existing login options. When logging into CDAS, you will be taken to RAS, where you can select your preferred login provider to access CDAS.

Browse Lab Results > 2006-0301

Trial Summary

About CDAS Project, PI, Publications: Cancer Genetic Markers of Susceptibility (CGEMS): Contribution of Breast Cancer Cases and Controls from PLCO Cancer Screening Trial

Datasets

Site: Misc

Inclusion Criteria:

  • All I-Arm Females
  • Supplemental Questionnaire
  • No prior history of any cancer prior to SQX
  • No confirmed or reported cancers
  • No rare cancers
  • Subjects are dead
  • No oral contraceptive use (BQ)
  • No current hormone use (SQX and BQ)
  • Has Biochemical Consent
  • Has Serum and Plasma Available
  • Has Perfect Serum and Plasma Available
  • Has Perfect T4/5 Serum and Plasma Available
  • Has Serum and Plasma Available at the same study year (Eligible)
  • Randomly selected 30 (Selected)

Match Ratio: Not Applicable

Match Technique: Not Applicable

Analytes:

  • C-Peptide
  • Insulin-like Growth Factor 1
  • Insulin-like Growth Factor 2
  • Insulin-like Growth Factor Binding Protein 3
  • Leptin

Number of Controls: 30